Mammotome
Mammotome manufactures medical products, specializing in vacuum-assisted biopsy systems for breast cancer detection.
Founded
1995Mammotome manufactures medical products, specializing in vacuum-assisted biopsy systems for breast cancer detection.
Founded with a mission to enhance breast cancer detection and treatment, Mammotome specializes in manufacturing medical products, particularly vacuum-assisted biopsy systems. The company aims to improve patient outcomes through innovative technologies like the HydroMARK™ Plus Marker and the Sentimag® Localization Platform, which offer enhanced visibility and ease of use for healthcare providers. Mammotome's market focus is on providing advanced diagnostic tools to medical professionals to facilitate early and accurate breast cancer diagnosis.
Mammotome has garnered recognition as a top workplace, reflecting its commitment to employee satisfaction and organizational excellence. The company has made significant strides in the medical field, with its products being widely adopted by healthcare providers globally. Notable achievements include the development of the HydroMARK™ Plus Marker, which addresses common challenges in breast cancer diagnostics. Mammotome's impact is evident in its contribution to improving the standard of care in breast cancer detection and treatment.
Companies similar to Mammotome include View Point Medical, Mirabel Medical Systems, Rubicor Medical and Gamma Medica-Ideas.
Mammotome was founded in 1995.
Mammotome's headquarters is located in Cincinnati, OH, US.
Mammotome's most recent funding round was for $14M (USD) in July 2010.
As of Jul 8, 2010, Mammotome has disclosed funding of $14M (USD). Undisclosed round amounts are excluded.
Mammotome has 525 employees as of Feb 4, 2024.
Gamma Medica-Ideas
